Metabolites
Displaying metabolites 3151 - 3175 of 3755 in total
| Metabolite ID | Name CAS Number | IUPAC Name | SMPDB Pathways | Weight Formula | Structure |
|---|---|---|---|---|---|
| ECMDB23870 | Aromatic amino acid | 2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid | 220.2246 C11H12N2O3 |  | |
| ECMDB01006 | Argininosuccinic acid 2387-71-5 | (2S)-2-{N'-[(4S)-4-amino-4-carboxybutyl]carbamimidamido}butanedioic acid | 290.2731 C10H18N4O6 |  | |
| ECMDB20117 | Arbutin 6-phosphate | {[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(4-hydroxyphenoxy)oxan-2-yl]methoxy}phosphonic acid | 352.2311 C12H17O10P |  | |
| ECMDB03458 | Aquacobalamin 13422-52-1 | cobalt(3+) ion 1-[(2S,3R,4S,5R)-3-hydroxy-4-{[hydroxy({[(2R)-1-({1-hydroxy-3-[(1R,3R,8S,13S,14S,18S,19S)-8,13,18-tris(2-carboximidatoethyl)-3,14,19-tris(C-hydroxycarbonimidoylmethyl)-1,4,6,9,9,14,16,19-octamethyl-20,21,22,23-tetraazapentacyclo[15.2.1.1²,⁵.1⁷,¹⁰.1¹²,¹⁵]tricosa-5(23),6,10(22),11,15(21),16-hexaen-4-yl]propylidene}amino)propan-2-yl]oxy})phosphoryl]oxy}-5-(hydroxymethyl)oxolan-2-yl]-5,6-dimethyl-3H-1λ⁵,3-benzodiazol-1-ylium hydrate | 1347.3631 C62H90CoN13O15P |  | |
| ECMDB23098 | aquacob(III)alamin | λ²-cobalt(2+) ion 1-[(2S,3R,4S,5R)-3-hydroxy-4-{[hydroxy({[(2R)-1-({1-hydroxy-3-[(1R,3R,4R,8S,13S,14S,18S,19S)-8,13,18-tris[2-(C-hydroxycarbonimidoyl)ethyl]-3,14,19-tris(C-hydroxycarbonimidoylmethyl)-1,4,6,9,9,14,16,19-octamethyl-20,21,22,23-tetraazapentacyclo[15.2.1.1²,⁵.1⁷,¹⁰.1¹²,¹⁵]tricosa-5(23),6,10(22),11,15(21),16-hexaen-4-yl]propylidene}amino)propan-2-yl]oxy})phosphoryl]oxy}-5-(hydroxymethyl)oxolan-2-yl]-5,6-dimethyl-3H-1λ⁵,3-benzodiazol-1-ylium hydrate | 1350.3869 C62H93CoN13O15P |  | |
| ECMDB24020 | Anserine | (2S)-2-(3-aminopropanamido)-3-(1-methyl-1H-imidazol-5-yl)propanoic acid | 240.259 C10H16N4O3 |  | |
| ECMDB24015 | Androsterone | (1S,2S,5R,7S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one | 290.4403 C19H30O2 |  | |
| ECMDB24082 | Amylose | 5-{[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-6-(hydroxymethyl)-2-methoxyoxane-3,4-diol | 370.3496 C14H26O11 |  | |
| ECMDB21186 | Ammonium | azanium | D-Alanine metabolism PW000768 More...Propanoate metabolism PW000940 D-Glutamine and D-glutamate metabolism PW000769 Amino sugar and nucleotide sugar metabolism I PW000886 Amino sugar and nucleotide sugar metabolism II PW000887 Amino sugar and nucleotide sugar metabolism III PW000895 Asparagine biosynthesis PW000813 L-alanine metabolism PW000788 L-glutamate metabolism PW000789 L-glutamate metabolism II PW001886 NAD biosynthesis PW000829 NAD salvage PW000830 Porphyrin metabolism PW000936 Vitamin B6 1430936196 PW000891 arginine metabolism PW000790 glycolate and glyoxylate degradation PW000827 isoleucine biosynthesis PW000818 ornithine metabolism PW000791 preQ0 metabolism PW001893 serine biosynthesis and metabolism PW000809 sulfur metabolism (butanesulfonate) PW000923 sulfur metabolism (ethanesulfonate) PW000925 sulfur metabolism (isethionate) PW000926 sulfur metabolism (methanesulfonate) PW000927 sulfur metabolism (propanesulfonate) PW000924 tryptophan metabolism II PW001916 Flavin biosynthesis PW001971 Phenylethylamine metabolism PW002027 Pyrimidine ribonucleosides degradtion PW002024 Uracil degradation III PW002026 N-acetylneuraminate and N-acetylmannosamine and N-acetylglucosamine degradation PW002030 Putrescine Degradation II PW002054 adenine and adenosine salvage I PW002069 adenine and adenosine salvage II PW002071 allantoin degradation (anaerobic) PW002050 purine deoxyribonucleosides degradation PW002077 purine ribonucleosides degradation PW002076 pyrimidine deoxyribonucleosides degradation PW002063 salvage pathways of pyrimidine deoxyribonucleotides PW002061 D-serine degradation PW002101 L-cysteine degradation PW002110 L-threonine degradation to methylglyoxal PW002106 adenosine nucleotides degradation PW002091 cyanate degradation PW002099 ethanolamine PW002094 pyrimidine ribonucleosides degradation PW002104 | 18.0385 H4N |  |
| ECMDB00051 | Ammonia 7664-41-7 | ammonia | Folate biosynthesis PW000908 More...Sulfur metabolism PW000922 Tryptophan metabolism PW000815 One carbon pool by folate PW000773 beta-Alanine metabolism PW000896 D-Glutamine and D-glutamate metabolism PW000769 Aspartate metabolism PW000787 L-glutamate metabolism PW000789 L-glutamate metabolism II PW001886 One Carbon Pool by Folate I PW001735 | 17.0305 H3N |  |
| ECMDB12189 | Aminopropylcadaverine 56-19-9 | (5-aminopentyl)(3-aminopropyl)amine | 159.2724 C8H21N3 |  | |
| ECMDB21430 | Aminomalonic acid 1068-84-4 | 2-aminopropanedioic acid | threonine biosynthesis PW000817 | 119.0761 C3H5NO4 |  |
| ECMDB00510 | Aminoadipic acid 542-32-5 | (2S)-2-aminohexanedioic acid | Lysine biosynthesis PW000771 | 161.1558 C6H11NO4 |  |
| ECMDB02134 | Aminoacetone 298-08-8 | 1-aminopropan-2-one | 73.0938 C3H7NO |  | |
| ECMDB20116 | Aminoacetaldehyde 645-36-3 | 2-aminoacetaldehyde | 59.0672 C2H5NO |  | |
| ECMDB20347 | alpha-N-acetylneuraminate | N-[(2R,4S,6R)-6-carboxy-4,6-dihydroxy-2-[(2S)-1,2,3-trihydroxypropyl]oxan-3-yl]ethanecarboximidate | 308.2619 C11H18NO9 |  | |
| ECMDB01388 | alpha-Linolenic acid 463-40-1 | (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid | 278.4296 C18H30O2 |  | |
| ECMDB00186 | alpha-Lactose 63-42-3 | (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxane-3,4,5-triol | 342.2965 C12H22O11 |  | |
| ECMDB00849 | alpha-L-Rhamnose 3615-41-6 | (2R,3R,4R,5R,6S)-6-methyloxane-2,3,4,5-tetrol | 164.1565 C6H12O5 |  | |
| ECMDB20264 | alpha-L-Fucose 2438-80-4 | (2R,3S,4R,5S,6S)-6-methyloxane-2,3,4,5-tetrol | fucose and rhamnose degradation PW000826 | 164.1565 C6H12O5 |  |
| ECMDB23945 | alpha-L-Fucopyranose 6696-41-9 | (2R,3S,4R,5S,6S)-6-methyloxane-2,3,4,5-tetrol | 164.1565 C6H12O5 |  | |
| ECMDB04092 | alpha-Ketoisovaleric acid 759-05-7 | 3-methyl-2-oxobutanoic acid | Pantothenate and CoA biosynthesis PW000828 | 116.1152 C5H8O3 |  |
| ECMDB02812 | alpha-Ketoglutarate | 2-oxopentanedioate | 144.0823 C5H4O5 |  | |
| ECMDB24218 | alpha-Kdo-(2→6)-lipid IVA | (2R,4R,5R,6R)-6-[(1R)-1,2-dihydroxyethyl]-4,5-dihydroxy-2-{[(2R,3S,4R,5R,6R)-6-{[(2R,3S,4R,5R,6R)-3-hydroxy-5-[(3R)-3-hydroxytetradecanamido]-4-{[(3R)-3-hydroxytetradecanoyl]oxy}-6-(phosphonatooxy)oxan-2-yl]methoxy}-5-[(3R)-3-hydroxytetradecanamido]-4-{[(3R)-3-hydroxytetradecanoyl]oxy}-3-(phosphonatooxy)oxan-2-yl]methoxy}oxane-2-carboxylate |  | ||
| ECMDB23937 | alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-[4-P-L-Ara4N]-lipid A | (2R,4R,5R,6R)-2-{[(2R,3S,4R,5R,6R)-3-[({[(2R,3R,4S,5S)-5-amino-3,4-dihydroxyoxan-2-yl]oxy}(hydroxy)phosphoryl)oxy]-5-[(3R)-3-(dodecanoyloxy)tetradecanamido]-6-{[(2R,3S,4R,5R,6R)-3-hydroxy-5-[(3R)-3-hydroxytetradecanamido]-4-{[(3R)-3-hydroxytetradecanoyl]oxy}-6-(phosphonooxy)oxan-2-yl]methoxy}-4-{[(3R)-3-(tetradecanoyloxy)tetradecanoyl]oxy}oxan-2-yl]methoxy}-4-{[(2R,4R,5R,6R)-2-carboxy-6-[(1R)-1,2-dihydroxyethyl]-4,5-dihydroxyoxan-2-yl]oxy}-6-[(1R)-1,2-dihydroxyethyl]-5-hydroxyoxane-2-carboxylic acid | 2369.88 C115H211N3O42P2 |  |